Divis Laboratories Ltd - DIVIS LAB. Share Price

Sector: Pharmaceuticals | ISIN: INE361B01024
₹ 4,392.10 (3.22%) icon28 May, 2024, 12:00:00 AM

Divis Laboratories Ltd KEY RATIOS

Divis Laboratories Ltd Corporate Actions

15 May , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Jan , 2024

12:00 AM

30 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

26 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

26 Oct , 2023

12:00 AM

03 Jul , 2023

12:00 AM

AGM

Announcement date: 03 Jul , 2023

View Details

05 Aug , 2023

12:00 AM

05 Aug , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

20 May , 2023

12:00 AM

Dividend

Dividend amount: 30
Announcement date: 20 May , 2023

View Details

No Record Found


Divis Laboratories Ltd News and Update

No Record Found

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Divis Laboratories Ltd SHAREHOLDING SNAPSHOT
29 May , 2024 | 07:47 AM

PROMOTER - TOTAL51.92%

Indian: 51.92%

Foreign: 0%

NON-PROMOTER - TOTAL 48.08%

Institutions: 36.89%

Non-Institutions: 11.19%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Divis Laboratories Ltd FINANCIALS

View Profit & Loss Graph

Divis Laboratories Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Divis Laboratories Ltd

  • Murali K Divi
  • Chairman & Managing Director
  • N V Ramana
  • Executive Director
  • Madhusudana Rao Divi
  • Whole Time Director (Projects)
  • Kiran S Divi
  • Whole Time Director & CEO
  • G Suresh Kumar
  • Independent Director
  • Ranga Rao Ravipati
  • Independent Director
  • K V K Seshavataram
  • Independent Director
  • Ramesh B V Nimmagadda
  • Chairman(Non Exe)&Director(Ind
  • Nilima Motaparti
  • Whole Time Director -Commercia
  • S Ganapaty
  • Independent Director
  • Sunaina Singh
  • Independent Director
  • Kosaraju Veerayya Chowdary
  • Independent Director
  • Satish Choudhury
  • Company Sec. & Compli. Officer

Summary

Divis Laboratories Ltd. is one of the leading pharmaceutical companies in the world, manufacturing Active Pharmaceutical Ingredients (APIs), Intermediates and Nutraceuticals. The Company is one of the worlds largest API companies, with two manufacturing units and a market presence across 100 countries. It is engaged in the manufacture of Active Pharmaceutical ingredients (APIs), Intermediates and Nutraceutical ingredients with predominance in exports. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. It is among the largest pharmaceutical companies in India with a portfolio of approx. 160 products across diverse therapeutic areas. Presently, it has 6 manufacturing facilities and market presence across several countries. The company has two subsidiaries M/s. Divis Laboratories (USA) Inc., in the United States of America and M/s. Divis Laboratories Europe AG in Switzerland for marketing its Nutra products and to provide a greater reach to customers within these regions. The company has Research Centers at Sanathnagar, Hyderabad and at the manufacturing sites. Research Centre at Sanathnagar primarily focuses on custom synthesis, contract research for MNC companies as also future generics involving processes like route design, route selection, establishing gram scale... Read More


Reports by Divis Laboratories Ltd


Reports by Divis Laboratories Ltd

Company FAQ

No Record Found